Redmile Group, LLC

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
43 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Redmile Group, LLC's trades of ADC Therapeutics SA's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-02 2026-04-02
S Sale
94,003 +38.2%
108.83
US$4,261,715 		94,003 +38.2% 108.83 US$4,261,715
2026-04-02 2026-04-02
S Sale
12,227 -9.9%
394.53
US$2,897,369 		12,227 -9.9% 394.53 US$2,897,369
2026-04-02 2026-04-01
S Sale
83,461 -8.1%
271.76
US$353,626 		83,461 -8.1% 271.76 US$353,626
2026-04-02 2026-04-01
S Sale
169,265 -1.1%
3.80
US$643,038 		169,265 -1.1% 3.80 US$643,038
2026-04-02 2026-03-31
S Sale
188,407 -1.4%
3.75
US$706,903 		188,407 -1.4% 3.75 US$706,903
2026-04-02 2026-03-31
S Sale
196,229 -1.3%
3.75
US$736,251 		196,229 -1.3% 3.75 US$736,251
2024-12-26 2024-12-20
B Purchase
397,964 +3.2%
1.68
US$668,580 		397,964 +3.2% 1.68 US$668,580
2024-12-26 2024-12-20
S Sale
341,633 -2.7%
1.68
US$573,943 		341,633 -2.7% 1.68 US$573,943
2024-12-20 2024-12-20
PrS Proposed sale
341,633
1.66
US$567,111 		341,633 1.66 US$567,111
2024-12-13 2024-12-11
B Purchase
50,000 +0.4%
3.81
US$190,500 		50,000 +0.4% 3.81 US$190,500
2024-12-13 2024-12-11
B Purchase
50,000 +0.4%
2.28
US$114,000 		50,000 +0.4% 2.28 US$114,000
2024-12-13 2024-12-11
B Purchase
50,000 +0.3%
3.81
US$190,500 		50,000 +0.3% 3.81 US$190,500
2024-12-13 2024-12-11
B Purchase
50,000 +0.3%
2.28
US$114,000 		50,000 +0.3% 2.28 US$114,000
2024-12-06 2024-12-04
S Sale
25,352 -0.2%
2.07
US$52,479 		25,352 -0.2% 2.07 US$52,479
2024-12-06 2024-12-04
B Purchase
133,371 +2.5%
1.25
US$166,714 		133,371 +2.5% 1.25 US$166,714
2024-12-06 2024-12-04
S Sale
133,371 -2.4%
1.25
US$166,714 		133,371 -2.4% 1.25 US$166,714
2024-12-04 2024-12-04
PrS Proposed sale
133,371
1.13
US$150,709 		133,371 1.13 US$150,709
2024-07-03 2024-07-01
B Purchase
400,000 +3.2%
2.81
US$1,124,000 		400,000 +3.2% 2.81 US$1,124,000
2024-07-03 2024-07-01
B Purchase
400,000 +2.6%
2.81
US$1,124,000 		400,000 +2.6% 2.81 US$1,124,000
2024-03-05 2024-03-01
US Absci Corp (ABSI)
B Purchase
222,222 +2.8%
4.50
US$999,999 		222,222 +2.8% 4.50 US$999,999
2023-12-28 2023-12-26
B Purchase
44,630 +0.3%
3.72
US$166,024 		44,630 +0.3% 3.72 US$166,024
2023-11-22 2023-11-20
US Augmedix Inc (AUGX)
B Purchase
750,000 +8.6%
4.00
US$3,000,000 		750,000 +8.6% 4.00 US$3,000,000
2023-11-22 2023-11-20
US Augmedix Inc (AUGX)
B Purchase
750,000 +4.8%
4.00
US$3,000,000 		750,000 +4.8% 4.00 US$3,000,000
2023-07-03 2023-06-29
B Purchase
80,423 +2.8%
9.42
US$757,585 		80,423 +2.8% 9.42 US$757,585
2023-07-03 2023-06-29
S Sale
80,423 -2.7%
9.42
US$757,585 		80,423 -2.7% 9.42 US$757,585
2023-04-21 2023-04-21
B Purchase
256,639 +2.0%
6.18
US$1,586,029 		256,639 +2.0% 6.18 US$1,586,029
2023-04-21 2023-04-20
B Purchase
20,000 +0.2%
5.99
US$119,800 		20,000 +0.2% 5.99 US$119,800
2023-04-17 2023-04-14
B Purchase
25,700 +0.2%
6.00
US$154,200 		25,700 +0.2% 6.00 US$154,200
2023-04-17 2023-04-14
S Sale
302,339 -2.3%
5.84
US$1,765,660 		302,339 -2.3% 5.84 US$1,765,660
2021-11-04 2021-11-02
B Purchase
1,000,000 +104.8%
20.00
US$20,000,000 		1,000,000 +104.8% 20.00 US$20,000,000
2021-11-01 2021-10-28
US Augmedix Inc (AUGX)
B Purchase
1,625,000 +12.7%
4.00
US$6,500,000 		1,625,000 +12.7% 4.00 US$6,500,000
2021-06-23 2021-06-21
B Purchase
1,050,000 +118.4%
19.00
US$19,950,000 		1,050,000 +118.4% 19.00 US$19,950,000
2021-01-12 2021-01-08
B Purchase
327,485 +2.6%
85.50
US$27,999,968 		327,485 +2.6% 85.50 US$27,999,968
2021-02-16 2020-12-28
S Sale
5,863 -0.3%
5.80
US$34,005 		5,863 -0.3% 5.80 US$34,005
2021-02-16 2020-12-28
S Sale
494,137 -21.8%
5.58
US$2,757,284 		494,137 -21.8% 5.58 US$2,757,284
2020-10-15 2020-10-14
B Purchase
50,000 +0.9%
22.10
US$1,105,000 		50,000 +0.9% 22.10 US$1,105,000
2020-10-15 2020-10-14
B Purchase
31,695 +0.6%
21.09
US$668,308 		31,695 +0.6% 21.09 US$668,308
2020-10-15 2020-10-14
B Purchase
65,047 +1.2%
20.00
US$1,300,797 		65,047 +1.2% 20.00 US$1,300,797
2020-10-15 2020-10-14
B Purchase
195,158 +3.7%
19.20
US$3,747,580 		195,158 +3.7% 19.20 US$3,747,580
2020-10-15 2020-10-14
B Purchase
158,100 +3.1%
18.01
US$2,847,666 		158,100 +3.1% 18.01 US$2,847,666
2020-10-15 2020-10-14
B Purchase
2,941,176 +135.0%
17.00
US$49,999,992 		2,941,176 +135.0% 17.00 US$49,999,992
2020-10-07 2020-10-05
US Augmedix Inc (AUGX)
B Purchase
5,000,000 +64.5%
3.00
US$15,000,000 		5,000,000 +64.5% 3.00 US$15,000,000
2020-09-09 2020-09-09
B Purchase
8,650 +0.3%
51.85
US$448,523 		8,650 +0.3% 51.85 US$448,523
2020-09-09 2020-09-09
B Purchase
14,610 +0.4%
52.96
US$773,811 		14,610 +0.4% 52.96 US$773,811
2020-09-09 2020-09-08
B Purchase
47,113 +1.4%
49.91
US$2,351,504 		47,113 +1.4% 49.91 US$2,351,504